Bruker (BRKR) Tops Q3 EPS by 11c

Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.42, $0.11 better than the analyst estimate of $0.31. Revenue for the quarter came in at $511.4 million versus the consensus estimate of $483.68 million.

Guidance Remains Suspended

Bruker’s FY 2020 financial guidance remains suspended. Bruker expects that the pandemic and related economic slowdown will continue to have a negative year-over-year impact on the Company’s fourth quarter 2020 financial results.

For earnings history and earnings-related data on Bruker (BRKR) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Accenture downgraded by TD Cowen on AI concerns
• Notice to Long-Term Shareholders of Badger Meter, Inc. (NYSE: BMI); GeneDx Holdings Corp. (NASDAQ: WGS); GRAIL, Inc. (NASDAQ: GRAL); and Verra Mobility Corporation (NASDAQ: VRRM): Grabar Law Office i